EBioMedicine

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
2014 has been a remarkable year of scientific achievements, from advances in our understanding of molecular pathways of human diseases to the development of new interventional tools to tackle them. Here, we highlight some promising initiatives and success stories from the past year with clear translational relevance. The list is by no means exhaustive but(More)
2015 has been an exciting year for cardiovascular research. Consecutive US FDA approvals of alirocumab in July and evolocumab in August meant that they were in the spotlight at the European Society of Cardiology and American Heart Association congresses—two of the largest annual meetings of cardiologists in the world. Thesemonoclonal antibodies (mAbs) bind(More)
  • 1